Cord blood expansion and other strategies to improve engraftment after umbilical cord blood transplantation
Agent/strategy . | Mechanism . | Clinical trial identifier . | Patients, N . | Median d to PMN engraftment . | Institution, country/manufacturer . | Author . | Reference . |
---|---|---|---|---|---|---|---|
Nicotinamide | Inhibits HSC differentiation and facilitates homing | NCT01816230 | 36 | 11.5 | Duke University, United States/Gamida Cell | Horwitz et al | 45 |
Notch ligand | Provides HSC proliferative signal | NCT01690520 | 10 | 16 | Fred Hutchinson Cancer Research Center, United States | Delaney et al | 43 |
Mesenchymal stem cells (Mesoblasts) | Provide signal for HSC expansion; improve stroma | NCT01854567 | 31 | 15 | MD Anderson Cancer Center, United States/Mesoblast | De Lima et al | 44 |
16,16-dimethyl prostaglandin E2 | Facilitates homing, proliferation, and self-renewal | NCT00890500 | 12 | 17 | Dana-Farber Cancer Institute, United States | Cutler et al | 53 |
Oral sitagliptin | DPP-IV inhibition | NCT00862719 | 24 | 21 | Indiana University School of Medicine, United States | Farag et al | 54 |
Complement fragment 3a priming | Facilitates homing | NCT00963872 | 29 | 7 | University of Minnesota, United States | Brunstein et al | 55 |
FT-VI | Fucosylation | NCT01471067 | 22 | 17 | MD Anderson Cancer Center, United States | Popat et al | 56 |
Aryl hydrocarbon receptor antagonist (StemRegenin1) | Blocking of HSC differentiation by SR-1 inhibition of aryl hydrocarbon receptor | NCT01474681 | 17 | 15 | University of Minnesota, United States | Wagner et al | 57 |
Intrabone infusion | Facilitates homing | NCT00696046 | 32 | 23 | University of Genoa, Italy | Frassoni et al | 58 |
Copper chelation (carlecortemcel-L) | Expansion by blocking HSC differentiation | NCT00469729 | 101 | 21 | Cardinal Bernardin Cancer Center, Loyola University, United States | Stiff et al | 59 |
Agent/strategy . | Mechanism . | Clinical trial identifier . | Patients, N . | Median d to PMN engraftment . | Institution, country/manufacturer . | Author . | Reference . |
---|---|---|---|---|---|---|---|
Nicotinamide | Inhibits HSC differentiation and facilitates homing | NCT01816230 | 36 | 11.5 | Duke University, United States/Gamida Cell | Horwitz et al | 45 |
Notch ligand | Provides HSC proliferative signal | NCT01690520 | 10 | 16 | Fred Hutchinson Cancer Research Center, United States | Delaney et al | 43 |
Mesenchymal stem cells (Mesoblasts) | Provide signal for HSC expansion; improve stroma | NCT01854567 | 31 | 15 | MD Anderson Cancer Center, United States/Mesoblast | De Lima et al | 44 |
16,16-dimethyl prostaglandin E2 | Facilitates homing, proliferation, and self-renewal | NCT00890500 | 12 | 17 | Dana-Farber Cancer Institute, United States | Cutler et al | 53 |
Oral sitagliptin | DPP-IV inhibition | NCT00862719 | 24 | 21 | Indiana University School of Medicine, United States | Farag et al | 54 |
Complement fragment 3a priming | Facilitates homing | NCT00963872 | 29 | 7 | University of Minnesota, United States | Brunstein et al | 55 |
FT-VI | Fucosylation | NCT01471067 | 22 | 17 | MD Anderson Cancer Center, United States | Popat et al | 56 |
Aryl hydrocarbon receptor antagonist (StemRegenin1) | Blocking of HSC differentiation by SR-1 inhibition of aryl hydrocarbon receptor | NCT01474681 | 17 | 15 | University of Minnesota, United States | Wagner et al | 57 |
Intrabone infusion | Facilitates homing | NCT00696046 | 32 | 23 | University of Genoa, Italy | Frassoni et al | 58 |
Copper chelation (carlecortemcel-L) | Expansion by blocking HSC differentiation | NCT00469729 | 101 | 21 | Cardinal Bernardin Cancer Center, Loyola University, United States | Stiff et al | 59 |
FT-VI, enzyme fucosyltransferase; DPP-IV, dipeptidylpeptidase IV; HSC, hematopoietic stem cell; PMN, polymorphonuclear leukocytes.